Genetics and Pathogenesis of Parkinson's Syndrome

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Parkinson's disease (PD) exhibits significant clinical, pathological, and genetic heterogeneity.
• Individual PD cases present unique syndromes with variable motor and non-motor features, overlapping with other neurodegenerative disorders.

Purpose of the Study:

• To explore the complex architecture of Parkinson's disease.
• To identify unifying biological mechanisms underlying PD pathogenesis.
• To highlight the potential for precision medicine strategies in PD treatment.

Main Methods:

• Review of clinical, pathological, and genetic data in Parkinson's disease.
• Analysis of alpha-synuclein protein pathology distribution and co-pathologies.
• Examination of genetic influences, including common and rare variants.
• Synthesis of insights from experimental genetic studies.

Main Results:

• Parkinson's disease is not a single disorder but a spectrum of unique syndromes.
• Alpha-synuclein pathology varies in distribution, often modified by other pathologies.
• Over 100 genes are implicated, with most cases arising from complex genetic variant interactions.
• Unifying themes in pathogenesis include synaptic, lysosomal, mitochondrial, and immune mechanisms.

Conclusions:

• Understanding PD's complex nature is crucial for effective treatment.
• Advances in biomarkers and targeted therapies support precision medicine approaches for Parkinson's disease.
• Future strategies will leverage genetic insights and biological mechanisms for personalized PD care.